More patients seek drugs through ADAPs, creating $50 million deficit.
The national AIDS Drug Assistance Program (ADAP) is $50 million short of averting an emergency this summer as states continue to see increases in the number of people applying for HIV medications through the program. A few states already have waiting lists, but many more might experience difficulties beginning in June, ADAP officials say. Meanwhile, congressional efforts to pass a Medicare drug benefit could have a positive effect on ADAPs, which have some clients who would be eligible for Medicare coverage, but this solution is a long way from becoming a reality.
D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D019458:Insurance Coverage; D007356:Insurance, Pharmaceutical Services; D008484:Medicaid / Q000458:organization & administration; D008483:Medical Assistance; D006278:Medicare / Q000458:organization & administration; D014481:United States
D019380:Anti-HIV Agents